Pharma News

Antimicrobial resistance is a major problem for human health and researchers worldwide are looking for new solutions. “We urgently need new antibiotics to combat bacteria that become increasingly resistant to most clinically used antibiotics,” says Dr. Markus Weingarth, a researcher from the Chemistry Department of Utrecht University.

Led by the National Human Genome Research Institute (NHGRI), a team of researchers at the National Institute of Standards and Technology (NIST) and many other organizations used advanced sequencing technologies to read out the full DNA sequence of the Y chromosome a  region of the genome that typically drives male reproductive development.

Hon’ble Shri Kalraj Mishra, Governor, Rajasthan presented the ET Leadership Excellence Award 2023 for significant contribution in the field of Health Management to Dr. P.R. Sodani, President of IIHMR University, Jaipur. Dr. P.R. Sodani has been a well-known Health Economist and Public Health Professor for more than two decades and has mentored faculty, students, and research scholars. He has made significant contributions through research in strengthening the Health Systems of Rajasthan.

The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, was apprised of a Memorandum of Understanding (MoU) signed on 4th June, 2023 between the Central Drugs Standard Control Organization (CDSCO), Ministry of Health and Family Welfare, Government of the Republic of India and Ministry of Health, Government of the Republic of Suriname on cooperation in the field of Medical Product Regulation. This was signed during the visit of the President of India to Suriname.

Government to open 25000 Jan Aushadhi Kendras to make medicines available at affordable prices. Prime Minister Shri Narendra Modi during his Independence Day speech at Red Fort said that the government has plans to increase the number of 'Jan Aushadhi Kendras' from 10,000 to 25,000.

Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

The Food and Drug Administration granted regular approval to pralsetinib (Gavreto, Genentech, Inc.) for adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.

Bristol Myers Squibb has launched Clear Understanding, a campaign featuring patients living with moderate to severe plaque psoriasis who are sharing what it’s really like for them to live with the disease from dealing with symptoms to navigating relationships with friends, family or co-workers to dispelling misconceptions about the condition.

Novartis announced that it has completed its acquisition of Chinook Therapeutics, Inc., a Seattle, WA, based biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines for kidney diseases, in a transaction valued at up to USD 3.5 billion.